Cargando…
Comparative Proteomic Analysis of Advanced Ovarian Cancer Tissue to Identify Potential Biomarkers of Responders and Nonresponders to First-Line Chemotherapy of Carboplatin and Paclitaxel
Conventional treatment for advanced ovarian cancer is an initial debulking surgery followed by chemotherapy combination of carboplatin and paclitaxel. Despite initial high response, three-fourths of these women experience disease recurrence with a dismal prognosis. Patients with advanced-stage ovari...
Autores principales: | Sehrawat, Urmila, Pokhriyal, Ruchika, Gupta, Ashish Kumar, Hariprasad, Roopa, Khan, Mohd Imran, Gupta, Divya, Naru, Jasmine, Singh, Sundararajan Baskar, Mohanty, Ashok Kumar, Vanamail, Perumal, Kumar, Lalit, Kumar, Sunesh, Hariprasad, Gururao |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Libertas Academica
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4795487/ https://www.ncbi.nlm.nih.gov/pubmed/26997873 http://dx.doi.org/10.4137/BIC.S35775 |
Ejemplares similares
-
Chemotherapy Resistance in Advanced Ovarian Cancer Patients
por: Pokhriyal, Ruchika, et al.
Publicado: (2019) -
2D-DIGE as a strategy to identify serum protein biomarkers to monitor pharmacological efficacy in dopamine-dictated states of Parkinson’s disease and schizophrenia
por: Gupta, Ashish Kumar, et al.
Publicado: (2019) -
Evaluation of Serum Apolipoprotein E as a Potential Biomarker for
Pharmacological Therapeutic Efficacy Monitoring in Dopamine Dictated Disease
Spectrum of Schizophrenia and Parkinson’s disease: A Preliminary
Study
por: Gupta, Ashish Kumar, et al.
Publicado: (2018) -
Cerebrospinal Fluid Proteomics For Identification Of α2-Macroglobulin As A Potential Biomarker To Monitor Pharmacological Therapeutic Efficacy In Dopamine Dictated Disease States Of Parkinson’s Disease And Schizophrenia
por: Gupta, Ashish Kumar, et al.
Publicado: (2019) -
Evaluation of α-synuclein and apolipoprotein E as potential biomarkers in cerebrospinal fluid to monitor pharmacotherapeutic efficacy in dopamine dictated disease states of Parkinson’s disease and schizophrenia
por: Gupta, Ashish Kumar, et al.
Publicado: (2019)